{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:43:34Z","timestamp":1777520614292,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bulcan.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T23:35:30Z","timestamp":1634081730000},"page":"1132-1144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Les strat\u00e9gies de d\u00e9sescalade pour les cancers diff\u00e9renci\u00e9s de la thyro\u00efde"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1161-5628","authenticated-orcid":false,"given":"Dana M.","family":"Hartl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Hadoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-1862","authenticated-orcid":false,"given":"Camilo","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abir Al","family":"Ghuzlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Guerlain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Breuskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3640-1204","authenticated-orcid":false,"given":"Livia","family":"Lamartina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bulcan.2021.07.008_bib0320","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00005537-200403000-00001","article-title":"Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer","volume":"114","author":"Shaha","year":"2004","journal-title":"Laryngoscope"},{"issue":"10","key":"10.1016\/j.bulcan.2021.07.008_bib0325","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1089\/thy.2017.0572","article-title":"Survival in differentiated thyroid cancer: comparing the AJCC cancer staging seventh and eighth editions","volume":"28","author":"Tam","year":"2018","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.bulcan.2021.07.008_bib0330","first-page":"55","article-title":"Differentiated and anaplastic thyroid carcinoma: major changes in the American joint committee on cancer eighth edition cancer staging manual","volume":"68","author":"Perrier","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bulcan.2021.07.008_bib0335","doi-asserted-by":"crossref","DOI":"10.1089\/thy.2017.0572","article-title":"Survival in differentiated thyroid cancer: comparing the AJCC Cancer staging 7th and 8th editions","author":"Tam","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.bulcan.2021.07.008_bib0340","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.oraloncology.2017.06.004","article-title":"Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma","volume":"71","author":"Kim","year":"2017","journal-title":"Oral Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2021.07.008_bib0345","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4158\/EP13029.OR","article-title":"Is above age 45\u00a0appropriate for upstaging well-differentiated papillary thyroid cancer?","volume":"19","author":"Bischoff","year":"2013","journal-title":"Endocr Pract"},{"issue":"2","key":"10.1016\/j.bulcan.2021.07.008_bib0350","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00268-017-4279-x","article-title":"Papillary thyroid carcinoma (PTC) in children and adults: comparison of initial presentation and long-term postoperative outcome in 4432\u00a0patients consecutively treated at the Mayo clinic during eight decades (1936-2015)","volume":"42","author":"Hay","year":"2018","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.bulcan.2021.07.008_bib0355","doi-asserted-by":"crossref","first-page":"e1683","DOI":"10.1210\/clinem\/dgaa935","article-title":"Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape","volume":"106","author":"Nies","year":"2021","journal-title":"J Clin Endocr Metab"},{"issue":"1","key":"10.1016\/j.bulcan.2021.07.008_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015\u00a0American Thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.bulcan.2021.07.008_bib0365","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1210\/jc.2012-3401","article-title":"Papillary thyroid cancer: time course of recurrences during postsurgery surveillance","volume":"98","author":"Durante","year":"2013","journal-title":"J Clin Endocr Metab"},{"issue":"7","key":"10.1016\/j.bulcan.2021.07.008_bib0370","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis","volume":"375","author":"Vaccarella","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bulcan.2021.07.008_bib0375","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejso.2017.03.004","article-title":"Low-risk papillary microcarcinoma of the thyroid: a review of active surveillance trials","volume":"44","author":"Ito","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.bulcan.2021.07.008_bib0380","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S2213-8587(16)30180-2","article-title":"Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?","volume":"4","author":"Leboulleux","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.bulcan.2021.07.008_bib0385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.bulcan.2021.07.008_bib0390","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00268-015-3392-y","article-title":"Clinical trials of active surveillance of papillary microcarcinoma of the thyroid","volume":"40","author":"Miyauchi","year":"2016","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.bulcan.2021.07.008_bib0395","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00268-009-0359-x","article-title":"Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes","volume":"34","author":"Sugitani","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.bulcan.2021.07.008_bib0400","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoto.2018.4131","article-title":"Patient experience of thyroid cancer active surveillance in Japan","author":"Davies","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.bulcan.2021.07.008_bib0405","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/thy.2015.0178","article-title":"A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma","volume":"26","author":"Brito","year":"2016","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.bulcan.2021.07.008_bib0410","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"American Thyroid Association Guidelines Taskforce on Thyroid","year":"2009","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.bulcan.2021.07.008_bib0415","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/SLA.0b013e31814697d9","article-title":"Extent of surgery affects survival for papillary thyroid cancer","volume":"246","author":"Bilimoria","year":"2007","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.bulcan.2021.07.008_bib0420","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/SLA.0000000000000925","article-title":"Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775\u00a0patients","volume":"260","author":"Adam","year":"2014","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.bulcan.2021.07.008_bib0425","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1089\/thy.2018.0554","article-title":"Lobectomy is feasible for 1-4\u00a0cm papillary thyroid carcinomas: a 10-year propensity score matched-pair analysis on recurrence","volume":"29","author":"Song","year":"2019","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.bulcan.2021.07.008_bib0430","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.surg.2013.04.068","article-title":"The impact of surgical volume on patient outcomes following thyroid surgery","volume":"154","author":"Kandil","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.bulcan.2021.07.008_bib0435","doi-asserted-by":"crossref","first-page":"d8041","DOI":"10.1136\/bmj.d8041","article-title":"Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study","volume":"344","author":"Duclos","year":"2012","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.bulcan.2021.07.008_bib0440","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1245\/s10434-014-3846-8","article-title":"Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons","volume":"21","author":"Hauch","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2021.07.008_bib0445","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000658-199809000-00005","article-title":"The importance of surgeon experience for clinical and economic outcomes from thyroidectomy","volume":"228","author":"Sosa","year":"1998","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.bulcan.2021.07.008_bib0450","doi-asserted-by":"crossref","first-page":"e013589","DOI":"10.1136\/bmjopen-2016-013589","article-title":"What is the care pathway of patients who undergo thyroid surgery in France and its potential pitfalls? A national cohort","volume":"7","author":"Mathonnet","year":"2017","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.bulcan.2021.07.008_bib0455","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1210\/jc.2012-1063","article-title":"Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies","volume":"97","author":"Verloop","year":"2012","journal-title":"J Clin Endocr Metab"},{"issue":"1","key":"10.1016\/j.bulcan.2021.07.008_bib0460","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.surg.2017.04.039","article-title":"Lobectomy for treatment of differentiated thyroid cancer: can patients avoid postoperative thyroid hormone supplementation and be compliant with the American Thyroid Association guidelines?","volume":"163","author":"Cox","year":"2018","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.bulcan.2021.07.008_bib0465","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00268-020-05482-6","article-title":"Diagnostic performance of neck ultrasonography in the preoperative evaluation for extrathyroidal extension of suspicious thyroid nodules","volume":"44","author":"Ramundo","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.bulcan.2021.07.008_bib0470","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jss.2019.04.036","article-title":"Lobectomy compared to total thyroidectomy for low-risk papillary thyroid cancer: a systematic review","volume":"242","author":"Vargas-Pinto","year":"2019","journal-title":"J Surg Res"},{"issue":"1","key":"10.1016\/j.bulcan.2021.07.008_bib0475","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.surg.2016.05.056","article-title":"Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine","volume":"161","author":"Kluijfhout","year":"2017","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.bulcan.2021.07.008_bib0480","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1089\/thy.2015.0495","article-title":"Frequency of high-risk characteristics requiring total thyroidectomy for 1-4\u00a0cm well-differentiated thyroid cancer","volume":"26","author":"Kluijfhout","year":"2016","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.bulcan.2021.07.008_bib0485","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/cen.13165","article-title":"The significance of unrecognized histological high-risk features on response to therapy in papillary thyroid carcinoma measuring 1-4\u00a0cm: implications for completion thyroidectomy following lobectomy","volume":"86","author":"Lang","year":"2017","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.bulcan.2021.07.008_bib0490","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/thy.2019.0274","article-title":"The identification of intraoperative risk factors can reduce, but not exclude, the need for completion thyroidectomy in low-risk papillary thyroid cancer patients","volume":"30","author":"Craig","year":"2020","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.bulcan.2021.07.008_bib0495","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1089\/thy.2017.0457","article-title":"Individualizing surgery in papillary thyroid carcinoma based on a detailed sonographic assessment of extrathyroidal extension","volume":"27","author":"Kuo","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.bulcan.2021.07.008_bib0500","doi-asserted-by":"crossref","DOI":"10.1002\/hed.26393","article-title":"Case for staged thyroidectomy","author":"Ronen","year":"2020","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.bulcan.2021.07.008_bib0505","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000354537","article-title":"2013\u00a0European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer","volume":"2","author":"Leenhardt","year":"2013","journal-title":"Eur Thyroid J"},{"issue":"8","key":"10.1016\/j.bulcan.2021.07.008_bib0510","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00268-013-2089-3","article-title":"Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma","volume":"37","author":"Hartl","year":"2013","journal-title":"World J Surg"},{"issue":"7","key":"10.1016\/j.bulcan.2021.07.008_bib0515","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00405-014-3104-5","article-title":"Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review","volume":"272","author":"Mamelle","year":"2015","journal-title":"Eur Arch Oto-Rhino-L"},{"issue":"9","key":"10.1016\/j.bulcan.2021.07.008_bib0520","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1007\/s00268-018-4547-4","article-title":"Prophylactic central neck dissection for papillary thyroid carcinoma with clinically uninvolved central neck lymph nodes: a systematic review and meta-analysis","volume":"42","author":"Chen","year":"2018","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.bulcan.2021.07.008_bib0525","doi-asserted-by":"crossref","first-page":"194","DOI":"10.21053\/ceo.2019.01634","article-title":"The effect of prophylactic central neck dissection during hemithyroidectomy on locoregional recurrence in patients with papillary thyroid carcinoma: a meta-analysis","volume":"13","author":"Ahn","year":"2020","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"8","key":"10.1016\/j.bulcan.2021.07.008_bib0530","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444\u00a0patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante","year":"2006","journal-title":"J Clin Endocr Metab"},{"issue":"11","key":"10.1016\/j.bulcan.2021.07.008_bib0535","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/hed.26417","volume":"42","author":"Singer","year":"2020","journal-title":"Head Neck"},{"issue":"26","key":"10.1016\/j.bulcan.2021.07.008_bib0540","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1200\/JCO.2015.61.6722","article-title":"Quality of life and cost-effectiveness assessment of radioiodine ablation strategies in patients with thyroid cancer: results from the randomized phase III ESTIMABL trial","volume":"33","author":"Borget","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2021.07.008_bib0545","article-title":"Association between pregnancy outcomes and radioactive iodine treatment after thyroidectomy among women with thyroid cancer","author":"Kim","year":"2019","journal-title":"JAMA Int Med"},{"key":"10.1016\/j.bulcan.2021.07.008_bib0550","article-title":"The effect of radioactive iodine therapy on ovarian function and fertility in female thyroid cancer patients: a systematic review and meta-analysis","author":"Piek","year":"2020","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.bulcan.2021.07.008_bib0555","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1089\/thy.2019.0560","article-title":"Long-term effects of radioiodine treatment on female fertility in survivors of childhood differentiated thyroid carcinoma","volume":"30","author":"Nies","year":"2020","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.bulcan.2021.07.008_bib0560","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clon.2008.03.010","article-title":"The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer","volume":"20","author":"Mallick","year":"2008","journal-title":"Clin Oncol"},{"issue":"18","key":"10.1016\/j.bulcan.2021.07.008_bib0565","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","article-title":"Strategies of radioiodine ablation in patients with low-risk thyroid cancer","volume":"366","author":"Schlumberger","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.bulcan.2021.07.008_bib0570","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2005-1185","article-title":"Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy","volume":"91","author":"Torlontano","year":"2006","journal-title":"J Clin Endocr Metab"},{"issue":"4","key":"10.1016\/j.bulcan.2021.07.008_bib0575","doi-asserted-by":"crossref","first-page":"101281","DOI":"10.1016\/j.beem.2019.05.005","article-title":"Risk-oriented concept of treatment for intrathyroid papillary thyroid cancer","volume":"33","author":"Hartl","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.bulcan.2021.07.008_bib0580","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41574-018-0068-3","article-title":"Follow-up of differentiated thyroid cancer\u00a0\u2013\u00a0what should (and what should not) be done","volume":"14","author":"Lamartina","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.bulcan.2021.07.008_bib0585","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2967\/jnumed.119.227652","article-title":"The genetic duet of BRAF V600E and TERT promoter mutations robustly predicts loss of radioiodine avidity in recurrent papillary thyroid cancer","volume":"61","author":"Liu","year":"2020","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.bulcan.2021.07.008_bib0590","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJMoa1209288","article-title":"Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer","volume":"368","author":"Ho","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2021.07.008_bib0595","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-21-0024","article-title":"Redifferentiation-facilitated radioiodine therapy in thyroid cancer","author":"Lamartina","year":"2021","journal-title":"Endocr Rela Cancer"},{"issue":"9940","key":"10.1016\/j.bulcan.2021.07.008_bib0600","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3\u00a0trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.bulcan.2021.07.008_bib0605","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1056\/NEJMc1503150","article-title":"Lenvatinib in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bulcan.2021.07.008_bib0610","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1078-0432.CCR-14-2915","article-title":"Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib","volume":"21","author":"Rothenberg","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.bulcan.2021.07.008_bib0615","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1210\/jc.2018-00612","article-title":"Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine","volume":"103","author":"Jaber","year":"2018","journal-title":"J Clin Endocr Metab"},{"issue":"5","key":"10.1016\/j.bulcan.2021.07.008_bib0620","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/jc.2018-01478","article-title":"Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers","volume":"104","author":"Dunn","year":"2019","journal-title":"J Clin Endocr Metab"},{"issue":"11","key":"10.1016\/j.bulcan.2021.07.008_bib0625","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1089\/thy.2019.0143","article-title":"Mitogen-activated protein kinase pathway inhibition for redifferentiation of radioiodine refractory differentiated thyroid cancer: an evolving protocol","volume":"29","author":"Iravani","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.bulcan.2021.07.008_bib0315","author":"Leboulleux\u00a0C.D.C.","year":"2021","journal-title":"Endo Congress"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121003672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121003672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:35:19Z","timestamp":1757792119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455121003672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0007455121003672"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.07.008","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les strat\u00e9gies de d\u00e9sescalade pour les cancers diff\u00e9renci\u00e9s de la thyro\u00efde","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}